SEC Form 4 · accession 0001214659-26-010664
IMAX CORP · IMAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Gelfond
Officer — Chief Executive Officer · Director
Period of report
Aug 18, 2026
Accepted (ET)
Aug 20, 2026 · 5:37 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000921582
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common sharesF1 | Aug 18, 2026 | C | 151,253 | $31.90 | A | 916,255 | D | |
| common sharesF2 | Aug 18, 2026 | S | 151,253 | $51.0049 | D | 765,002 | D | |
| common sharesF1 | Aug 19, 2026 | C | 205,504 | $31.90 | A | 970,506 | D | |
| common sharesF2 | Aug 19, 2026 | S | 205,504 | $53.2656 | D | 765,002 | D | |
| common shares | Aug 20, 2026 | S | 100,000 | $53.2337 | D | 665,002 | D | |
| common shares (opening balance) | holding | — | — | — | 765,002 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| stock options (to buy)F3,F5,F4 | $31.90 | Aug 18, 2026 | C | 151,253 | D | — | Jan 3, 2027 | common shares | 151,253 | 1,181,158 | D |
| stock options (to buy)F3,F5,F4 | $31.90 | Aug 19, 2026 | C | 205,504 | D | — | Jan 3, 2027 | common shares | 205,504 | 975,654 | D |
Explanation of responses
- F1Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
- F2Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
- F3These options were issued in 2017 and are set to expire on January 3, 2027.
- F4The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019.
- F5This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively.